Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs.

Bone Marrow Transplant · 2019 · PMC6320344 · PMID 29795422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients treated during the plerixafor showed a trend towards fewer apheresis sessions, lower total apheresis blood volume and less time spent on apheresis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.